menu
    • menu

    Find Fosinopril manufacturers, exporters & distributors on PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    8

    API Suppliers

    API Suppliers

    6

    USDMF

    US DMFs Filed

    4

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    2

    EU WC

    EU WC

    0

    KDMF

    KDMF

    3

    NDC API

    NDC API

    0

    VMF

    NDC API

    4

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 1,923

    MARKET PLACE

    1

    API

    0

    FDF

    4INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    122

    FDF Dossiers

    FDF Dossiers

    56

    FDA Orange Book

    FDA (Orange Book)

    44

    Europe

    Europe

    8

    Canada

    Canada

    4

    Australia

    Australia

    6

    South Africa

    South Africa

    4

    Listed Dossiers

    Listed Dossiers

    0 DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    8

    EDQM

    8

    USP

    0

    JP

    9

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    3

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    1

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    5,354,834

    Annual Reports

    NA

    Finished Drug Prices

    Listed Dossiers

    181 RELATED EXCIPIENT COMPANIES

    292EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Fosinopril sodium, 88889-14-9, Chebi:5164, 1217528-56-7, Dynacil, Eliten
    Molecular Formula
    C30H45NNaO7P
    Molecular Weight
    585.6  g/mol
    InChI Key
    TVTJZMHAIQQZTL-HREVRLCXSA-M
    Fosinopril
    A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat.
    1 2D Structure

    Fosinopril

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    sodium;(2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate
    2.1.2 InChI
    InChI=1S/C30H46NO7P.Na/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24;/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35);/q;+1/p-1/t25-,26+,30?,39?;/m1./s1
    2.1.3 InChI Key
    TVTJZMHAIQQZTL-HREVRLCXSA-M
    2.1.4 Canonical SMILES
    CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)[O-])C3CCCCC3.[Na+]
    2.1.5 Isomeric SMILES
    CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)[O-])C3CCCCC3.[Na+]
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. Dynacil

    2. Fosenopril

    3. Fosinil

    4. Fosinopril

    5. Fosinopril Sodium

    6. Fosinopril, (1(s*(r*)),2 Alpha,4 Alpha)-(d-pro)-isomer

    7. Fosinopril, (1(s*(r*)),2 Alpha,4 Beta)-isomer

    8. Fosinopril, (1(s*(s*)),2 Alpha,4 Beta)-isomer

    9. Fosinorm

    10. Fositens

    11. Fozitec

    12. Hiperlex

    13. Monopril

    14. Newace

    15. Sodium, Fosinopril

    16. Sq 28,555

    17. Sq 28555

    18. Sq-28,555

    19. Sq-28555

    20. Sq28,555

    21. Sq28555

    22. Staril

    23. Tenso Stop

    24. Tensocardil

    2.2.2 Depositor-Supplied Synonyms

    1. Fosinopril Sodium

    2. 88889-14-9

    3. Chebi:5164

    4. 1217528-56-7

    5. Dynacil

    6. Eliten

    7. Sodium;(2s,4s)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylate

    8. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate

    9. Fosinopril Sodium- Bio-x

    10. Ncgc00167432-01

    11. Dsstox_cid_26621

    12. Dsstox_rid_81772

    13. Dsstox_gsid_46621

    14. Schembl40690

    15. Chembl3188382

    16. Dtxsid7046621

    17. Tox21_112436

    18. Mfcd00897699

    19. Akos015888700

    20. Ac-6227

    21. Bcp9000703

    22. Bs-1003

    23. Sq28555

    24. Bf164489

    25. Cas-88889-14-9

    26. A842989

    27. Sodium (2s,4s)-4-cyclohexyl-1-({[2-methyl-1-(propanoyloxy)propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate

    28. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-

    29. Sodium (2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)-(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate

    30. Sodium (2s,4s)-4-cyclohexyl-1-(2-{[2-methyl-1-(propionyloxy) Propoxy](4-phenylbutyl)phosphoryl}acetyl)pyrrolidine-2-carboxylate

    31. Sodium(2s,4s)-4-cyclohexyl-1-(2-((2-methyl-1-(propionyloxy)propoxy)(4-phenylbutyl)phosphoryl)acetyl)pyrrolidine-2-carboxylate

    2.3 Create Date
    2008-02-05
    3 Chemical and Physical Properties
    Molecular Weight 585.6 g/mol
    Molecular Formula C30H45NNaO7P
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count15
    Exact Mass585.28313405 g/mol
    Monoisotopic Mass585.28313405 g/mol
    Topological Polar Surface Area113 Ų
    Heavy Atom Count40
    Formal Charge0
    Complexity857
    Isotope Atom Count0
    Defined Atom Stereocenter Count2
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameFosinopril sodium
    Drug LabelFosinopril sodium tablet, USP is the sodium salt of fosinopril USP, the ester prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. It contains a phosphinate group capable of specific binding to the active site of angiotensin con...
    Active IngredientFosinopril sodium
    Dosage FormTablet
    RouteOral
    Strength10mg; 40mg; 20mg
    Market StatusPrescription
    CompanyActavis Labs Fl; Teva; Apotex; Aurobindo Pharma; Sandoz; Invagen Pharms

    2 of 2  
    Drug NameFosinopril sodium
    Drug LabelFosinopril sodium tablet, USP is the sodium salt of fosinopril USP, the ester prodrug of an angiotensin converting enzyme (ACE) inhibitor, fosinoprilat. It contains a phosphinate group capable of specific binding to the active site of angiotensin con...
    Active IngredientFosinopril sodium
    Dosage FormTablet
    RouteOral
    Strength10mg; 40mg; 20mg
    Market StatusPrescription
    CompanyActavis Labs Fl; Teva; Apotex; Aurobindo Pharma; Sandoz; Invagen Pharms

    5 Pharmacology and Biochemistry
    5.1 MeSH Pharmacological Classification

    Angiotensin-Converting Enzyme Inhibitors

    A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)

    Antihypertensive Agents

    Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

    5.2 FDA Pharmacological Classification
    5.2.1 Pharmacological Classes
    Angiotensin-converting Enzyme Inhibitors [MoA]; Angiotensin Converting Enzyme Inhibitor [EPC]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"FOSINOPRIL","year":"2021","qtr":"Q1","strtotime":1611167400,"product":"FOSINOPRIL SODIUM PH.EUR BATCH NOS:FO201 10024 FO20120025","address":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD-A.P.","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"ALMATY","customer":"JSC CHIMPHARM.","customerCountry":"KAZAKHSTAN","quantity":"70.00","actualQuantity":"70","unit":"KGS","unitRateFc":"1903.4","totalValueFC":"134902.9","currency":"USD","unitRateINR":140948.20999999999,"date":"21-Jan-2021","totalValueINR":"9866374.7","totalValueInUsd":"134902.9","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"8070143","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"KAZAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD-A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"FOSINOPRIL","year":"2021","qtr":"Q1","strtotime":1615228200,"product":"FOSINOPRIL SODIUM USP","address":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD-A.P.","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"108.81","actualQuantity":"108.81","unit":"KGS","unitRateFc":"1947.6","totalValueFC":"209730.2","currency":"USD","unitRateINR":140323.94798272217,"date":"09-Mar-2021","totalValueINR":"15268648.78","totalValueInUsd":"209730.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9221128","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD-A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626978600,"product":"FOSINOPRIL SODIUM USP","address":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD-A.P.","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"215.54","actualQuantity":"215.54","unit":"KGS","unitRateFc":"1979.3","totalValueFC":"412444","currency":"USD","unitRateINR":142609.77015867125,"date":"23-Jul-2021","totalValueINR":"30738109.86","totalValueInUsd":"412444","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3336956","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD-A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1638901800,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"MAKIZ PHARMA LTD","customerCountry":"RUSSIA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"145120","totalValueFC":"1789.8","currency":"RUB","unitRateINR":135000,"date":"08-Dec-2021","totalValueINR":"135000","totalValueInUsd":"1789.8","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6600511","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641925800,"product":"FOSINOPRIL SODIUM PH.EUR","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"YELGRAD (BEOGRAD)","customer":"FHI ZDRAVLJE A.D.LESKOVAC","customerCountry":"SERBIA","quantity":"35.75","actualQuantity":"35.75","unit":"KGS","unitRateFc":"2100","totalValueFC":"73993.1","currency":"USD","unitRateINR":154181.81818181818,"date":"12-Jan-2022","totalValueINR":"5512000","totalValueInUsd":"73993.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"7440501","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SERBIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643999400,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"231.16","actualQuantity":"231.16","unit":"KGS","unitRateFc":"1950","totalValueFC":"445095.8","currency":"USD","unitRateINR":144328.60356463055,"date":"05-Feb-2022","totalValueINR":"33363000","totalValueInUsd":"445095.8","indian_port":"HYDERABAD ICD","hs_no":"29339990","bill_no":"8007096","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646677800,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"177.70","actualQuantity":"177.7","unit":"KGS","unitRateFc":"1950","totalValueFC":"340595.2","currency":"USD","unitRateINR":146088.91389983118,"date":"08-Mar-2022","totalValueINR":"25960000","totalValueInUsd":"340595.2","indian_port":"HYDERABAD ICD","hs_no":"29339990","bill_no":"8773312","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD ICD","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649269800,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"JSC BIOCOM","customerCountry":"RUSSIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"1950","totalValueFC":"96794","currency":"USD","unitRateINR":146060,"date":"07-Apr-2022","totalValueINR":"7303000","totalValueInUsd":"96794","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9547849","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663007400,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"TO THE ORDER OF","customerCountry":"TAIWAN","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"2270","totalValueFC":"55577","currency":"USD","unitRateINR":178160,"date":"13-Sep-2022","totalValueINR":"4454000","totalValueInUsd":"55577","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"4155635","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696530600,"product":"FOSINOPRIL SODIUM PH.EUR","address":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA","city":"HYDERABAD-A.P.","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"N\/A","customer":"N\/A","customerCountry":"KAZAKHSTAN","quantity":"110.00","actualQuantity":"110","unit":"KGS","unitRateFc":"1495","totalValueFC":"162437.1","currency":"USD","unitRateINR":122904.77272727272,"date":"06-Oct-2023","totalValueINR":"13519525","totalValueInUsd":"162437.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"4451733","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"KAZAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"HETERO HOUSE, H.NO.8-3-166\/7\/1ERRAGADDA, HYDERABAD-A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725042600,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE,","city":"HYDERABAD, TELANGANA","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"91.48","actualQuantity":"91.48","unit":"KGS","unitRateFc":"1950","totalValueFC":"175997.1","currency":"USD","unitRateINR":161372.80935723655,"date":"31-Aug-2024","totalValueINR":"14762384.6","totalValueInUsd":"175997.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3632397","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"7-2-A2, HETERO CORPORATE,, HYDERABAD, TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725993000,"product":"FOSINOPRIL SODIUM USP","address":"7-2-A2, HETERO CORPORATE,","city":"HYDERABAD, TELANGANA","supplier":"HETERO DRUGS","supplierCountry":"INDIA","foreign_port":"NEW YORK - JOHN F. K","customer":"INVAGEN PHARMACEUTICALS INC","customerCountry":"UNITED STATES","quantity":"117.58","actualQuantity":"117.58","unit":"KGS","unitRateFc":"1950","totalValueFC":"226570.9","currency":"USD","unitRateINR":161480.84835856437,"date":"11-Sep-2024","totalValueINR":"18986918.15","totalValueInUsd":"226570.9","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"3929402","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"7-2-A2, HETERO CORPORATE,, HYDERABAD, TELANGANA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1641321000,"product":"RE-IMPORT FOSINOPRIL SODIUM, USP (SB NO. 2342780 DT. 27.03.2020)","address":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con","city":"HYDERABAD","supplier":"INVAGEN PHARMACEUTICALS INC","supplierCountry":"INDIA","foreign_port":"#N\/A","customer":"HETERO DRUGS","customerCountry":"INDIA","quantity":"20.00","actualQuantity":"20","unit":"KGS","unitRateFc":"2000","totalValueFC":"41426.5","currency":"USD","unitRateINR":"154300","date":"05-Jan-2022","totalValueINR":"3086000","totalValueInUsd":"41426.5","indian_port":"MADRAS AIR","hs_no":"29339990","bill_no":"6961818","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"#N\/A","supplierAddress":"","customerAddress":"7-2-A2, HETERO CORPORATE, INDUSTRIAL ESTATE, SANATHNAGAR, Con"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1651861800,"product":"FOSINOPRIL SODIUM PH.EUR","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"1380","totalValueFC":"68789.5","currency":"USD","unitRateINR":"106329","date":"07-May-2022","totalValueINR":"5316450","totalValueInUsd":"68789.5","indian_port":"HYDERABAD AIR","hs_no":"29241900","bill_no":"8577260","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"FOSINOPRIL RELATED COMPOUND F(QTY: 1X0.08 GMS,PRICE: USD 609.36)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00008","unit":"KGS","unitRateFc":"7617000","totalValueFC":"627.2","currency":"USD","unitRateINR":"611592500","date":"18-Jun-2022","totalValueINR":"48927.4","totalValueInUsd":"627.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"FOSINOPRIL RELATED COMPOUND F(QTY: 1X0.2 GMS,PRICE: USD 1509.81)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"7549050","totalValueFC":"1553.9","currency":"USD","unitRateINR":"606136600","date":"18-Jun-2022","totalValueINR":"121227.32","totalValueInUsd":"1553.9","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"FOSINOPRIL RELATED COMPOUND F(QTY: 2X15 MG,PRICE: USD 806\/EACH)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.00003","unit":"KGS","unitRateFc":"53733333.3","totalValueFC":"1659.1","currency":"USD","unitRateINR":"4314416000","date":"18-Jun-2022","totalValueINR":"129432.48","totalValueInUsd":"1659.1","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655490600,"product":"FOSINOPRIL SODIUM(QTY: 1X200 MG,PRICE: USD 257)(FOC)","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIAL ","supplierCountry":"INDIA","foreign_port":"NA","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0002","unit":"KGS","unitRateFc":"1285000","totalValueFC":"264.5","currency":"USD","unitRateINR":"103176650","date":"18-Jun-2022","totalValueINR":"20635.33","totalValueInUsd":"264.5","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"9166190","productDescription":"Re-Import","marketType":"REGULATED MARKET","country":"INDIA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1668623400,"product":"FOSINOPRIL SODIUM PH.EUR","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"1380","totalValueFC":"35424.6","currency":"USD","unitRateINR":"115644","date":"17-Nov-2022","totalValueINR":"2891100","totalValueInUsd":"35424.6","indian_port":"HYDERABAD AIR","hs_no":"29241900","bill_no":"3345942","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690482600,"product":"FOSINOPRIL SODIUM PH.EUR","address":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET","city":"HYDERABAD","supplier":"ZHEJIANG HUAHAI PHARMACEUTICAL","supplierCountry":"CHINA","foreign_port":"NA","customer":"AUROBINDO PHARMA LIMITED","customerCountry":"INDIA","quantity":"200.00","actualQuantity":"200","unit":"KGS","unitRateFc":"1380","totalValueFC":"278553.7","currency":"USD","unitRateINR":"114470.9","date":"28-Jul-2023","totalValueINR":"22894200.32","totalValueInUsd":"278553.7","indian_port":"HYDERABAD AIR","hs_no":"29241900","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.2, MAITRIVIHAR BEHIND MAITRIVANAM, AMEERPET"}]
    21-Jan-2021
    11-Sep-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Fillers, Diluents & Binders

    read-more
    read-more

    Direct Compression

    read-more
    read-more

    Disintegrants & Superdisintegrants

    read-more
    read-more

    Granulation

    read-more
    read-more

    Lubricants & Glidants

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Controlled & Modified Release

    read-more
    read-more

    Chewable & Orodispersible Aids

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Taste Masking

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Rheology Modifiers

    read-more
    read-more

    API Stability Enhancers

    read-more
    read-more

    Coloring Agents

    read-more
    read-more

    Surfactant & Foaming Agents

    read-more
    read-more

    Topical

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    USP

    read-more
    read-more

    ABOUT THIS PAGE

    FOSINOPRIL SODIUM Manufacturers

    A FOSINOPRIL SODIUM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of FOSINOPRIL SODIUM, including repackagers and relabelers. The FDA regulates FOSINOPRIL SODIUM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. FOSINOPRIL SODIUM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

    click here to find a list of FOSINOPRIL SODIUM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

    FOSINOPRIL SODIUM Suppliers

    A FOSINOPRIL SODIUM supplier is an individual or a company that provides FOSINOPRIL SODIUM active pharmaceutical ingredient (API) or FOSINOPRIL SODIUM finished formulations upon request. The FOSINOPRIL SODIUM suppliers may include FOSINOPRIL SODIUM API manufacturers, exporters, distributors and traders.

    click here to find a list of FOSINOPRIL SODIUM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

    FOSINOPRIL SODIUM USDMF

    A FOSINOPRIL SODIUM DMF (Drug Master File) is a document detailing the whole manufacturing process of FOSINOPRIL SODIUM active pharmaceutical ingredient (API) in detail. Different forms of FOSINOPRIL SODIUM DMFs exist exist since differing nations have different regulations, such as FOSINOPRIL SODIUM USDMF, ASMF (EDMF), JDMF, CDMF, etc.

    A FOSINOPRIL SODIUM DMF submitted to regulatory agencies in the US is known as a USDMF. FOSINOPRIL SODIUM USDMF includes data on FOSINOPRIL SODIUM's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The FOSINOPRIL SODIUM USDMF is kept confidential to protect the manufacturer’s intellectual property.

    click here to find a list of FOSINOPRIL SODIUM suppliers with USDMF on PharmaCompass.

    FOSINOPRIL SODIUM CEP

    A FOSINOPRIL SODIUM CEP of the European Pharmacopoeia monograph is often referred to as a FOSINOPRIL SODIUM Certificate of Suitability (COS). The purpose of a FOSINOPRIL SODIUM CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of FOSINOPRIL SODIUM EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of FOSINOPRIL SODIUM to their clients by showing that a FOSINOPRIL SODIUM CEP has been issued for it. The manufacturer submits a FOSINOPRIL SODIUM CEP (COS) as part of the market authorization procedure, and it takes on the role of a FOSINOPRIL SODIUM CEP holder for the record. Additionally, the data presented in the FOSINOPRIL SODIUM CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the FOSINOPRIL SODIUM DMF.

    A FOSINOPRIL SODIUM CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. FOSINOPRIL SODIUM CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

    click here to find a list of FOSINOPRIL SODIUM suppliers with CEP (COS) on PharmaCompass.

    FOSINOPRIL SODIUM WC

    A FOSINOPRIL SODIUM written confirmation (FOSINOPRIL SODIUM WC) is an official document issued by a regulatory agency to a FOSINOPRIL SODIUM manufacturer, verifying that the manufacturing facility of a FOSINOPRIL SODIUM active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting FOSINOPRIL SODIUM APIs or FOSINOPRIL SODIUM finished pharmaceutical products to another nation, regulatory agencies frequently require a FOSINOPRIL SODIUM WC (written confirmation) as part of the regulatory process.

    click here to find a list of FOSINOPRIL SODIUM suppliers with Written Confirmation (WC) on PharmaCompass.

    FOSINOPRIL SODIUM NDC

    National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing FOSINOPRIL SODIUM as an active pharmaceutical ingredient (API).

    Finished drug products

    The FDA updates the NDC directory daily. The NDC numbers for FOSINOPRIL SODIUM API and other APIs are published in this directory by the FDA.

    Unfinished drugs

    The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

    Pharmaceutical companies that manufacture FOSINOPRIL SODIUM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

    Compounded drug products

    The NDC directory also contains data on finished compounded human drug products that contain FOSINOPRIL SODIUM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a FOSINOPRIL SODIUM NDC to their finished compounded human drug products, they may choose to do so.

    click here to find a list of FOSINOPRIL SODIUM suppliers with NDC on PharmaCompass.

    FOSINOPRIL SODIUM GMP

    FOSINOPRIL SODIUM Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

    GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

    PharmaCompass offers a list of FOSINOPRIL SODIUM GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right FOSINOPRIL SODIUM GMP manufacturer or FOSINOPRIL SODIUM GMP API supplier for your needs.

    FOSINOPRIL SODIUM CoA

    A FOSINOPRIL SODIUM CoA (Certificate of Analysis) is a formal document that attests to FOSINOPRIL SODIUM's compliance with FOSINOPRIL SODIUM specifications and serves as a tool for batch-level quality control.

    FOSINOPRIL SODIUM CoA mostly includes findings from lab analyses of a specific batch. For each FOSINOPRIL SODIUM CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

    FOSINOPRIL SODIUM may be tested according to a variety of international standards, such as European Pharmacopoeia (FOSINOPRIL SODIUM EP), FOSINOPRIL SODIUM JP (Japanese Pharmacopeia) and the US Pharmacopoeia (FOSINOPRIL SODIUM USP).

    Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
    For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search